CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
Activity
Last price
$299.02
Change
3.77 (1.28%)
Bid/Ask
$297.90 - $299.05
Volume
1.14M
Volume traded/total %
0.24%
Volume avg (4w)
630,153.00
Open
$295.00
Day range
$293.64 - $299.02
Previous Close
$295.25
Last Trade
20 Jan, 5:10 am UTC
Size
Market Cap
$142.37B
Market Rank
3
Industry Rank
1
Fundamentals
Shares Issued
482.22M
Earnings Per Share (EPS)
$6.98
Dividends Per Share (DPS)
$3.18
P/E Ratio
42.83
Similar to
Related Stories
Grafa
Whale trade in CSL (ASX:CSL)
Grafa
CSL (ASX:CSL) announces a board change
Grafa
Csl (ASX:Csl) full year profit dips
Grafa
CSL (ASX:CSL) CEO Paul Perreault to retire
Grafa
Csl (ASX:Csl) has announced a dividend
Skip for now >
FIRST THINGS FIRST
See all your stocks, crypto and forex on your personalised watchlist
Grafa reacts to your watchlist, so you get data, news and insights about the assets you care about.